Related Experiment Video
Updated: Jun 15, 2026
07:35
Methods for Studying the Mechanisms of Action of Antipsychotic Drugs in Caenorhabditis elegans
Published on: February 4, 2014
Behavioral indices in antipsychotic drug discovery
Roger D Porsolt1, Paul C Moser, Vincent Castagné
1Porsolt & Partners Pharmacology, Boulogne-Billancourt, France. rporsolt@porsolt.com
Summary
Current animal models for antipsychotic drug development show limited translational validity for predicting efficacy and side effects in humans, particularly for cognitive and negative symptoms. Further refinement is needed for accurate prediction of antipsychotic effectiveness and extrapyramidal symptoms (EPS).
Area of Science:
- Neuroscience
- Pharmacology
- Translational Medicine
Background:
- Schizophrenia presents with positive, negative, and cognitive symptoms, challenging current antipsychotic treatments.
- Classical antipsychotics are effective for positive symptoms but cause extrapyramidal symptoms (EPS).
- Novel antipsychotics aim for broader efficacy and reduced EPS, necessitating improved predictive models.
Purpose of the Study:
- To review and assess the translational validity of existing animal models for predicting antipsychotic efficacy.
- To evaluate the ability of animal models to predict extrapyramidal symptoms (EPS) liability.
- To identify gaps and guide the development of more predictive preclinical models for antipsychotics.
Main Methods:
- Review of rodent and non-human primate models for positive, negative, and cognitive symptoms of schizophrenia.
- Analysis of procedures assessing neurotransmitter systems (dopamine, glutamate, serotonin) relevant to positive symptoms.
- Evaluation of models for negative symptoms (anhedonia, social interaction deficits) and cognitive deficits (attention, memory).
- Assessment of animal models for predicting EPS, including parkinsonism, dystonia, akathisia, and tardive dyskinesia.
Main Results:
- Animal models show promise for predicting efficacy related to dopamine, NMDA, and serotonin pathways.
- Models for negative symptoms and cognitive deficits (attention, learning, memory) demonstrate variable translational validity.
- Established models for assessing EPS liability (catalepsy, chewing, defecation) show higher translational relevance.
Conclusions:
- Current animal models for antipsychotics possess limited translational validity, especially for cognitive and negative symptoms.
- Notable exceptions exist for predicting attention, learning/memory, and EPS liability, offering some predictive value.
- Significant improvements in translational validity are required for animal models to reliably guide antipsychotic drug development.
Related Concept Videos
01:21Antipsychotic Drugs: Typical and Atypical Agents
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:21Antipsychotic Drugs: Therapeutic Uses and Side Effects
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...